Rheumatoid arthritis nursing: pathophysiology, DMARDs, and NCLEX review

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily targets synovial joints. Left untreated, it causes progressive joint destruction, functional disability, and significant extra-articular complications including cardiovascular disease, pulmonary involvement, and vasculitis. With roughly 1.3 million Americans affected — and global prevalence between 0.5% and 1% — RA is one of the most common inflammatory arthritides nurses will encounter across practice settings. Understanding its immunologic mechanism, diagnostic framework, pharmacologic management, and nursing priorities is essential for safe, competent care.

Fast-scan summary: key rheumatoid arthritis facts

Pathophysiology

RA begins with a loss of self-tolerance to citrullinated proteins, a post-translational modification that triggers production of anti-citrullinated protein antibodies (ACPAs), more commonly known clinically as anti-CCP antibodies. The precise trigger for citrullination is not fully established, but genetic susceptibility (particularly HLA-DR4 and HLA-DR1 shared epitope alleles) combined with environmental exposures — most notably cigarette smoking — are strongly implicated in disease initiation. This antibody response can precede clinical symptoms by years.

Once autoimmunity is established, CD4+ T helper cells (particularly Th1 and Th17 subtypes) infiltrate the synovium. They activate macrophages and synovial fibroblasts, driving release of pro-inflammatory cytokines: tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). These cytokines sustain a self-perpetuating inflammatory cycle that causes the synovial lining to proliferate into a destructive mass of inflammatory tissue called pannus. Pannus invades cartilage directly and activates osteoclasts via the RANK-RANKL axis, leading to periarticular bone erosion.

The downstream effects are characteristic: synovial fluid becomes turbid and warm, the joint capsule distends, and — over time — cartilage thins and bony erosions develop. Chronic synovitis leads to weakening of periarticular tendons and ligaments, producing the deformities hallmark of advanced RA: ulnar deviation at the MCP joints, boutonnière deformity (PIP flexion with DIP hyperextension), and swan-neck deformity (PIP hyperextension with DIP flexion).

Chronic systemic inflammation also drives the extra-articular manifestations of RA: rheumatoid nodules (subcutaneous granulomas at pressure points), pericarditis, pleuritis, interstitial lung disease, vasculitis, and accelerated atherosclerosis.

Epidemiology

RA affects approximately 0.5–1% of the global population. In the United States, prevalence is approximately 1.3 million. It is 2–3 times more common in women than in men. Peak onset typically occurs between ages 40 and 60, though RA can develop at any age. Disease severity tends to be greater in seropositive patients (RF- and anti-CCP–positive) and in those who smoke. Patients with first-degree relatives with RA have a 3–5 times elevated risk compared to the general population.

Clinical presentation

Articular features

The hallmark presentation is symmetric polyarthritis affecting small joints of the hands and feet. The metacarpophalangeal (MCP) joints, proximal interphalangeal (PIP) joints, wrists, and metatarsophalangeal (MTP) joints are the most commonly and early-affected sites. A key clinical differentiator: RA characteristically spares the distal interphalangeal (DIP) joints — DIP involvement instead suggests osteoarthritis or psoriatic arthritis.

Morning stiffness lasting more than 1 hour is one of the most diagnostically meaningful symptoms of RA. It reflects the pooling of inflammatory cytokines in synovial fluid during periods of rest and improves progressively with activity — the opposite pattern of osteoarthritis, where pain typically worsens with use.

On examination, affected joints are warm, swollen, and tender. The swelling is soft (synovitis) rather than bony (as in OA). As disease progresses without treatment, joint deformities develop:

• Ulnar deviation — MCP joints deviate toward the ulnar side
• Boutonnière deformity — PIP flexion with DIP hyperextension
• Swan-neck deformity — PIP hyperextension with DIP flexion
• Z-deformity of the thumb — MCP flexion with IP hyperextension

Perform a thorough musculoskeletal assessment at every clinical encounter; the head-to-toe assessment framework provides a useful structure for systematic joint evaluation.

Extra-articular manifestations

RA is a systemic disease. Extra-articular involvement correlates with disease severity and seropositivity.

Rheumatoid nodules — subcutaneous, non-tender, firm nodules found over pressure points (olecranon, Achilles tendon, sacrum). Present in 20–30% of RA patients; more common with high RF titers.

Pulmonary involvement — includes pleural effusion, interstitial lung disease (ILD), rheumatoid nodules in the lungs, and bronchiectasis. ILD is a leading cause of death in severe RA.

Cardiovascular disease — RA confers approximately double the risk of MI and stroke compared to the general population. Chronic systemic inflammation accelerates atherosclerosis. Pericarditis and pericardial effusion also occur.

Felty syndrome — triad of RA + splenomegaly + neutropenia. Occurs in severe, long-standing, seropositive disease. Patients are at high risk for serious infections due to neutropenia.

Sjögren overlap — secondary Sjögren syndrome occurs in up to 30% of RA patients, presenting with xerostomia (dry mouth) and xerophthalmia (dry eyes).

Vasculitis — small-vessel vasculitis causes skin ulcers, digital ischemia, and peripheral neuropathy. Associated with high disease activity and high RF titers. Wound assessment protocols apply when vasculitic ulcers are present — refer to the wound assessment resource for systematic skin evaluation.

Ocular — episcleritis and scleritis; scleromalacia perforans in severe disease.

Atlantoaxial subluxation — discussed in detail in the complications section below. Critical safety concern in any RA patient requiring intubation or neck manipulation.

Diagnostic criteria

The 2010 ACR/EULAR Classification Criteria for RA replaced the older 1987 criteria, with improved sensitivity for early disease. A score of ≥6 out of 10 is required for classification as definite RA.

Note: The criteria apply to patients with at least one joint with definite clinical synovitis not explained by another diagnosis. Patients with erosive disease typical of RA on imaging, or with long-standing disease who would have met 2010 criteria at presentation, can also be classified.

Laboratory findings

Lab evaluation in RA serves three purposes: diagnosis, monitoring disease activity, and monitoring for medication toxicity. Interpretation of CBC, CRP, ESR, and other panels is covered in the nursing lab values cheat sheet.

Imaging

Conventional X-ray remains the standard for long-term structural monitoring. Early findings include periarticular osteopenia and soft-tissue swelling. Advanced findings include joint space narrowing (cartilage loss), periarticular erosions (especially at MCP and PIP joints), and eventually joint destruction with subluxation.

MRI is more sensitive for early disease — it can detect synovitis, bone marrow edema, and erosions before they appear on plain X-ray. Used when early diagnosis is uncertain or when cervical spine instability (atlantoaxial subluxation) requires evaluation.

Ultrasound with power Doppler can detect active synovitis and guide joint injections. Increasingly used in rheumatology clinics for disease activity assessment.

Cervical spine X-rays or MRI are indicated in RA patients with neck pain, neurological symptoms, or before any procedure requiring neck flexion or intubation — see the atlantoaxial subluxation discussion in the complications section.

Medical management

Disease-modifying antirheumatic drugs (DMARDs)

DMARDs are the cornerstone of RA treatment. Unlike NSAIDs and corticosteroids, DMARDs alter the underlying disease course by suppressing the autoimmune process. Early, aggressive DMARD therapy (“treat-to-target”) is the standard of care — the target is remission or low disease activity.

Medication administration rights and DMARD patient education are covered in the medication rights nursing reference.

Biologics

Biologic DMARDs are targeted therapies that block specific inflammatory mediators. They are used when conventional DMARDs (especially MTX) provide inadequate disease control, typically defined as persistent moderate-to-high disease activity after 3–6 months of optimized cDMARD therapy. All biologics carry an increased risk of serious infection due to immunosuppression. For a full overview of immunosuppressant drug classes, see the drug classifications nursing reference.

NSAIDs and corticosteroids

NSAIDs (ibuprofen, naproxen, celecoxib) provide analgesic and anti-inflammatory benefit but do not modify disease course. They are used as bridging therapy or for symptom control alongside DMARDs. Key nursing concerns: GI toxicity (consider PPI co-prescription), cardiovascular risk (COX-2 inhibitors and high-dose NSAIDs increase CV events), renal effects (avoid in CKD, monitor creatinine), and fluid retention. NSAID use can also affect electrolyte balance — particularly sodium and potassium — through effects on renal prostaglandins.

Corticosteroids (prednisone, methylprednisolone) are powerful anti-inflammatory agents used as bridging therapy when starting or optimizing DMARDs, and for managing flares. They provide rapid symptom relief but have significant long-term toxicities: glucose dysregulation, hypertension, weight gain, osteoporosis (see osteoporosis nursing for corticosteroid-induced bone loss), adrenal suppression, cataracts, and increased infection risk. The goal is always to taper to the lowest effective dose as DMARDs take effect. Long-term corticosteroid use also causes electrolyte disturbances (hypernatremia, hypokalemia) — reviewed in detail in the electrolyte imbalances nursing reference.

Corticosteroids should not be abruptly discontinued after prolonged use due to hypothalamic-pituitary-adrenal (HPA) axis suppression. Teach patients never to stop steroids suddenly.

Nursing assessment and interventions

Assessment priorities

Joint assessment: Document each affected joint — location, symmetry, warmth, swelling, tenderness, range of motion, and deformity. Use a consistent joint count (28-joint DAS28 is the standard in rheumatology; nursing assessments track a simplified version). Morning stiffness duration is a key activity marker — document the number of minutes stiffness lasts after waking.

Functional assessment: Evaluate ability to perform ADLs — grip strength, fine motor tasks (buttoning, writing), ambulation, and transfers. The Health Assessment Questionnaire (HAQ) is the validated tool used in RA — higher scores correlate with greater disability.

Pain assessment: Use a validated 0–10 numeric scale. Assess character (aching, burning, throbbing), timing (constant vs. intermittent), aggravating factors (rest vs. activity — RA is worse after rest), and relieving factors. Document both current pain and pain over the past 24 hours.

Medication monitoring: Check for signs of toxicity: CBC trends (bone marrow suppression from MTX or leflunomide), LFT trends (hepatotoxicity), respiratory symptoms (MTX pneumonitis), and injection site reactions (biologics).

Infection surveillance: Immunosuppressed patients are at elevated risk for bacterial, fungal, and opportunistic infections. Monitor vital signs, CBC, and clinical symptoms. Patients on tocilizumab may not febrile with infection — use CRP and clinical judgment rather than fever alone. Any patient with signs of serious infection requires prompt escalation; see the sepsis nursing reference for sepsis recognition and response protocols.

Fall risk: Joint deformity, pain, and impaired mobility increase fall risk. Assess using Morse Fall Scale. Ensure environment is free of hazards. Consider occupational therapy referral for adaptive equipment. DVT risk increases with immobility during flares — see the DVT nursing reference for thromboprophylaxis considerations.

Nursing diagnoses and interventions

Patient education

Effective patient education is fundamental to RA management outcomes. Patients who understand their disease make better adherence decisions and recognize problems earlier.

Medication adherence

DMARDs require weeks to months before full therapeutic effect is apparent. Patients frequently discontinue medications prematurely when they don’t notice immediate improvement, or during symptom remission when they feel “cured.” Emphasize that remission is the result of the medication working — not a sign it can be stopped. Teach specific monitoring schedules: MTX patients must have CBC and LFTs drawn at regular intervals even when asymptomatic. Explain the rationale for weekly (not daily) MTX dosing and the critical importance of folic acid supplementation.

Biologics require specific storage and administration instructions. SC injections should be taught with return demonstration before discharge. Refrigerated biologics should not be frozen. Injection sites should be rotated.

Infection warning signs

All patients on DMARDs and biologics must know which symptoms require urgent medical evaluation: fever over 100.4°F (38°C), increasing joint redness/warmth out of proportion to usual inflammation, respiratory symptoms (cough, dyspnea), skin breakdown, urinary symptoms, or any signs of sepsis. Patients on tocilizumab must understand that they may not develop fever with serious infection — any feeling of being unwell warrants prompt contact with their provider.

Patients on JAK inhibitors should be counseled about herpes zoster risk and the availability of zoster vaccine (ideally given before starting therapy, as live vaccines are contraindicated once immunosuppression begins).

Joint protection techniques

Joint protection reduces mechanical stress on inflamed and damaged joints:

• Use the largest, strongest joint possible for a task (push doors with your shoulder, not your fingers)
• Avoid tight pinch grip — use palmar grip instead
• Distribute loads across multiple joints (carry bags over the forearm, not by the handles in the fingers)
• Use adaptive equipment — jar openers, built-up utensils, long-handled tools
• Splint acutely inflamed joints during high-demand activities
• Maintain joint alignment — avoid sustained positions that stress inflamed joints (prolonged tight grip, wrist hyperflexion)
• Rest inflamed joints during active flares, but maintain gentle ROM to prevent contracture

Exercise and activity

Low-impact exercise is beneficial in RA — it maintains muscle strength (which supports and protects joints), improves cardiovascular fitness (addressing the elevated CV risk), and reduces fatigue and depression. Swimming, cycling, and walking are well-tolerated. High-impact activities should be avoided during active flares. Physical therapy should be initiated early and continued as needed.

Avoid complete bed rest except during severe flares — prolonged immobility accelerates muscle wasting, bone loss, and DVT risk.

Regular lab monitoring

Teach patients that routine lab draws are not optional — they detect toxicity before it becomes clinically dangerous. Patients on MTX who miss regular CBCs risk undetected bone marrow suppression; those on leflunomide who skip LFT monitoring risk silent hepatotoxicity. Frame monitoring as proactive self-care, not just provider convenience.

Complications

Joint deformities

Progressive joint destruction without treatment leads to the classic RA deformities described earlier: ulnar deviation, boutonnière, and swan-neck deformities. Once structural damage occurs, it is largely irreversible — this is the strongest argument for early aggressive DMARD initiation. Deformities impair grip strength, ADL performance, and quality of life.

Atlantoaxial subluxation (C1–C2 instability)

This is among the most clinically significant RA complications from a nursing and anesthesia safety standpoint. Chronic inflammation of the synovial joints and transverse ligament at the C1–C2 level allows the atlas (C1) to sublux anteriorly on the axis (C2), potentially compressing the spinal cord or vertebral arteries.

Clinical significance for nurses: Any RA patient scheduled for procedures requiring neck manipulation, general anesthesia with intubation, or cervical spine procedures requires evaluation for atlantoaxial subluxation. Inform the anesthesia team of RA diagnosis before any intubation. Avoid hyperflexion or hyperextension of the neck in RA patients with known or suspected cervical instability. Symptoms include occipital headache, neck pain, upper extremity weakness or paresthesia, and signs of cervical myelopathy.

Cardiovascular disease

RA carries approximately twice the cardiovascular risk of the general population. Chronic systemic inflammation accelerates atherosclerosis, and traditional CV risk factors (hypertension, dyslipidemia, diabetes, smoking) are more prevalent in RA. Effective RA treatment reduces, but does not eliminate, excess CV risk. Nursing responsibilities include monitoring blood pressure, lipids, and blood glucose; encouraging smoking cessation; and facilitating regular CV risk screening.

Secondary osteoporosis

Both the chronic inflammatory process and long-term corticosteroid use cause significant bone loss. RA patients on corticosteroids should be on bone-protective therapy (calcium, vitamin D; bisphosphonate if indicated) — see the osteoporosis nursing reference for full management details.

Lymphoma

Patients with severe, long-standing RA have a 2- to 3-fold elevated risk of B-cell lymphoma compared to the general population. This appears to be driven primarily by disease severity and duration (immune dysregulation from active RA) rather than by DMARD or biologic therapy, though the relationship is complex. Rituximab (anti-CD20) is sometimes used in RA precisely because of its oncology application.

Drug-related complications

• MTX: Hepatic fibrosis/cirrhosis with long-term use (mitigated by folic acid and regular LFT monitoring); pulmonary toxicity (MTX pneumonitis — presents with dyspnea, cough, and hypoxia; requires prompt drug discontinuation)
• Leflunomide: Serious teratogenicity; hepatotoxicity; hypertension
• TNF inhibitors: Reactivation of latent TB; demyelinating disease; heart failure exacerbation (avoid in NYHA Class III/IV HF)
• JAK inhibitors: Boxed warning for MACE, serious infections, DVT/PE, and malignancy

RA vs. osteoarthritis comparison

Differentiating RA from osteoarthritis is a classic NCLEX examination topic. The two conditions have fundamentally different pathophysiology, joint distribution, and management.

NCLEX practice questions

Question 1

A nurse is caring for a patient newly diagnosed with rheumatoid arthritis who is starting methotrexate therapy. Which nursing instruction is most important?

A) Take methotrexate every morning with breakfast B) Avoid all physical activity while on methotrexate C) Take folic acid 1 mg daily to reduce medication side effects D) Expect full symptom relief within 48 hours of the first dose

Correct answer: C

Rationale: Folic acid supplementation (1 mg/day) is standard of care with methotrexate. It reduces GI toxicity (nausea, mucositis), hepatotoxicity, and bone marrow suppression without diminishing the anti-inflammatory efficacy of the drug. Option A is incorrect — methotrexate for RA is given weekly, not daily; daily dosing causes severe, potentially fatal toxicity. Option B is incorrect — moderate activity is beneficial in RA. Option D is incorrect — DMARDs require 6–12 weeks for full therapeutic effect.

Question 2

A patient with severe, long-standing rheumatoid arthritis is being prepared for elective knee surgery under general anesthesia. Which nursing action is the highest priority before the procedure?

A) Confirm the patient took their morning dose of methotrexate B) Assess for signs of atlantoaxial subluxation and notify the anesthesiologist C) Apply compression stockings to both lower extremities D) Obtain a current CRP level to assess disease activity

Correct answer: B

Rationale: Atlantoaxial subluxation (C1–C2 instability) is a potentially life-threatening complication of long-standing RA. Intubation with neck hyperextension can compress the spinal cord or vertebral arteries if the atlas has subluxed on the axis. The anesthesiologist must be informed of the RA diagnosis so appropriate neck precautions and evaluation (cervical spine X-ray or MRI if indicated) can be undertaken before intubation. Options C and D represent appropriate but lower-priority perioperative nursing actions.

Question 3

A nursing student is reviewing two patients with arthritis. Patient A has joint stiffness that lasts 90 minutes each morning and improves after moving around. Patient B has joint stiffness that lasts about 20 minutes in the morning and worsens throughout the day with activity. Which statement correctly differentiates these patients?

A) Patient A most likely has osteoarthritis; Patient B most likely has rheumatoid arthritis B) Patient A most likely has rheumatoid arthritis; Patient B most likely has osteoarthritis C) Both patients likely have the same condition with different severity D) Morning stiffness duration is not a reliable differentiator between arthritis types

Correct answer: B

Rationale: Morning stiffness lasting more than 1 hour that improves with activity is characteristic of inflammatory arthritis, particularly RA. This reflects the accumulation of inflammatory mediators in the joint during rest (“gelling phenomenon”) that dissipates with movement. In contrast, OA produces brief morning stiffness (typically less than 30 minutes) that worsens with prolonged activity. This distinction is one of the most tested RA differentiators on NCLEX.

Question 4

A nurse reviewing a patient’s laboratory results sees the following: RF negative, anti-CCP 450 units/mL (reference range <20), ESR 68 mm/hr, CRP 42 mg/L. The patient has symmetric MCP and PIP joint swelling. The most appropriate nursing action is to:

A) Report the negative RF as inconsistent with RA and prepare patient for alternate diagnosis B) Recognize that the anti-CCP result is the most specific lab indicator for RA and document accordingly C) Withhold all lab results until the rheumatologist confirms the diagnosis D) Reorder the RF test as the result may be a false negative

Correct answer: B

Rationale: Anti-CCP (anti-citrullinated protein antibody) is the most specific lab test for RA, with specificity of approximately 95–98%. A strongly positive anti-CCP is highly indicative of RA even when RF is negative — this scenario is called “seronegative” RA by RF but positive by anti-CCP. Approximately 20–30% of RA patients are RF-negative. A negative RF does not rule out RA. The nurse should document findings and communicate them to the provider in context of the full clinical picture.

Question 5

A nurse is preparing to administer the first dose of adalimumab (Humira) to a patient with rheumatoid arthritis. Which pre-administration assessment is most critical?

A) Blood pressure measurement B) Completion of tuberculosis (TB) screening with negative result C) Latest anti-CCP titer D) Patient’s fasting glucose level

Correct answer: B

Rationale: TNF inhibitors (including adalimumab, etanercept, and infliximab) are contraindicated in patients with active tuberculosis and require pre-treatment screening for latent TB (TST or IGRA). TNF-α plays a critical role in containing mycobacterial infections by maintaining granuloma integrity. TNF inhibition releases this containment and can lead to rapid dissemination of latent TB. If latent TB is identified, treatment with isoniazid for at least 1 month before starting biologic therapy is required. Adalimumab must also be held during any active infection — including bacterial, viral, and fungal.

Question 6

A patient with rheumatoid arthritis asks the nurse why the doctor recommended using a padded jar opener instead of gripping jars with bare hands. The best nursing response is:

A) “Jar openers prevent you from overusing your arms, which can trigger flares.” B) “Using adaptive equipment distributes force across larger joints and reduces mechanical stress on inflamed finger joints.” C) “Gripping tight objects increases the risk of spreading infection to your hands.” D) “Jar openers are easier to use and have nothing to do with your arthritis specifically.”

Correct answer: B

Rationale: Joint protection techniques are a cornerstone of RA occupational therapy. The principle is to reduce mechanical stress on the small, inflamed joints of the hands by using the largest, strongest joints available for any given task. A jar opener shifts the effort from the small MCP and PIP joints (already damaged by pannus and synovitis) to the larger wrist and forearm structures. Similarly, patients are taught to carry bags over the forearm rather than by finger handles, use palmar rather than pinch grip, and use built-up utensil handles. These techniques slow joint deformity progression and reduce pain.

Related resources

Rheumatoid arthritis management touches multiple body systems and clinical domains. The following resources provide essential supporting knowledge:

• Osteoporosis nursing — Secondary osteoporosis from chronic inflammation and corticosteroid use is nearly universal in poorly controlled RA. Bone-protective strategies are integral to RA management.
• Electrolyte imbalances nursing — NSAIDs and corticosteroids both affect renal electrolyte handling. Sodium, potassium, and fluid status require monitoring in patients on long-term corticosteroids.
• Nursing lab values cheat sheet — CBC, CRP, ESR, and LFT interpretation for DMARD monitoring and disease activity assessment.
• Head-to-toe assessment — Systematic musculoskeletal assessment framework applicable to joint evaluation in RA.
• Medication rights nursing — Principles of safe DMARD administration and patient education.
• Drug classifications nursing — Overview of biologic and immunosuppressant drug classes including TNF inhibitors, IL-6 inhibitors, and JAK inhibitors.
• Sepsis nursing — Immunosuppressed RA patients are at elevated risk for sepsis. Early recognition and rapid response are critical.
• DVT nursing — Immobility during RA flares, combined with JAK inhibitor use (boxed warning for thrombosis), increases DVT/PE risk.
• Wound assessment — Vasculitic ulcers and pressure injuries require systematic wound evaluation in RA patients with severe systemic disease.